Research goal
Cognitive
Peptides studied for neuroprotection, neurotrophin upregulation, BDNF modulation, and dopaminergic system support — the research landscape of cognitive peptides.
Cognitive Peptide Research
Cognitive peptides are compounds studied for their effects on neurological function, neuroprotection, and neuroplasticity. Research in this area examines peptide interactions with neurotrophins (BDNF, NGF), dopaminergic and serotonergic systems, and structural markers of neurodegeneration.
Key Research Areas
Neurotrophin Upregulation
GHK-Cu upregulates both brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) at the gene expression level, as documented in the Pickart & Margolina 2018 gene atlas (PMID: 29987172). BDNF plays a central role in synaptic plasticity, long-term potentiation, and neuronal survival.
Dopaminergic & Serotonergic Modulation
BPC-157 modulates both dopaminergic and serotonergic systems. Research shows it can normalise dopamine receptor expression altered by dopamine-depleting agents and attenuates serotonin syndrome in animal models — making it a subject of interest in neurological recovery research.
Growth Hormone Axis & Brain Function
GH deficiency is associated with cognitive decline, reduced hippocampal volume, and impaired memory consolidation. Ipamorelin and Sermorelin are studied as tools to restore physiological GH pulsatility, with secondary interest in their neuroprotective and cognitive effects.
Frequently Asked Questions
What peptides are studied for cognitive function? GHK-Cu (neurotrophin upregulation), BPC-157 (dopaminergic modulation), Ipamorelin (GH-axis cognitive effects), and Sermorelin (GHRH receptor signalling) are the most studied cognitive peptides in the Aevitas catalog. Each acts through a different neurological mechanism.
Research Use Only · Not for human consumption.